Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

FREDUN PHARMACEUTICALS LTD.

NSE : NABSE : 539730ISIN CODE : INE194R01017Industry : Pharmaceuticals & DrugsHouse : Private

BSE1748.00117.25 (+7.19 %)

PREV CLOSE ( ) 1630.75

OPEN PRICE ( ) 1682.00

BID PRICE (QTY) 1740.00 (17)

OFFER PRICE (QTY) 1748.00 (1)

VOLUME 4973

TODAY'S LOW / HIGH ( )1657.70 1844.00

52 WK LOW / HIGH ( ) 6351999

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 08-06 1987

Management Info

Daulat Medhora - Chairman Fredun Medhora - Managing Director

Registered Office

Address 11th Floor, Tower A,Urmi Estate 95, Ganpatrao Kadam Marg,Lower Parel (West),
Mumbai,
Maharashtra-400013

Phone 022-40318111

Email business@fredungroup.com

Website www.fredungroup.com

Registrars Details

Purva Shareregistry (India) Pvt Ltd

Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai

Listing : BSE

NEWS

29Nov Fredun Pharmaceuticals informs about
Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (List..

13Oct Fredun Pharmaceuticals launches ‘Snack
Fredun Pharmaceuticals has launched -- ‘Snacky Jain’, India’s first Jain..

13Oct Fredun Pharmaceuticals informs about
Fredun Pharmaceuticals has informed that it enclosed press release title..

13Oct Fredun Pharmaceuticals zooms on launch
Fredun Pharmaceuticals is currently trading at Rs. 1491.00, up by 60.90..

10Oct Fredun Pharmaceuticals moves up on acq
Fredun Pharmaceuticals is currently trading at Rs. 1430.00, up by 11.30..

Financials

Rs. in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	97.3100000000001	208.08
Gross Profit	130.05	282.71
Operating Profit	223.34	550.97
Net Sales	1452.91	4562.68

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Alkem Laboratories (BSE) 5637.55 (1.37%)	M.Cap ( in Cr)67433.46
Abbott India (BSE) 28110.00 (0.25%)	M.Cap ( in Cr)59751.97
Astrazeneca Pharma I (BSE) 9130.95 (0.76%)	M.Cap ( in Cr)22794.75
Ajanta Pharma (BSE) 2690.05 (2.58%)	M.Cap ( in Cr)33532.72
NGL Fine-Chem (BSE) 1335.00 (4.35%)	M.Cap ( in Cr)824.77

Shareholding Pattern

	NON-INSTITUTION	49.45%
	PROMOTERS	48.93%
	FI/BANKS/INSURANCE	1.59%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

FREDUN PHARMACEUTICALS LTD.